Loading…

Allow analytics cookies and session replay? Accepting lets us link visits and completed actions to your account when signed in. Declining keeps cookieless usage counts. The site works either way. Privacy policy

Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 505–508 of 508 KOLs

Sort

Drug: Osimertinib✕

Krishna Alluri, MD

Basic profileOncologyHematology / OncologySouth Central · TX

—
publications: —
h-index: 18
companies

View profile →

Susan Bates, MD

NewYork-Presbyterian

Enriched profileBreastMedical OncologyNortheast · NY

—
publications: —
h-index: 14
trials

View profile →

Melissa Johnson, MD

Sarah Cannon Research Institute

Enriched profileOncologyMedical OncologySoutheast · TN

—
publications: —
h-index: 11
trials

View profile →

Julio Peguero, MD

Oncology Consultants

Enriched profileOncologyMedical OncologySouth Central · TX

—
publications: —
h-index: 75
companies

View profile →

← PrevPage 22 of 22Next →

FindMyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Infectious Disease
Neurology
Rare/Genetic
Dermatology
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Rheumatology/Immunology
Nephrology
Ophthalmology
Hematology
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
West
Southeast
Midwest
South Central
All regions →

About

Directory
Top experts by indication
KOL finder
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 FindMyKOL